Integrated Drug Substance-Drug Product development
Products
Information
Process R&D, Custom manufacturing, formulation development, Clinical supplies, safety assessment
Syngene International Ltd.
Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated contract research, development and manufacturing organisation providing scientific services -- from early discovery to commercial supply. Our innovative capabilities for novel molecular entities (NMEs) cater to pharma, biotech, nutrition, animal health, consumer goods and speciality chemical companies
Log in
See all the content and easy-to-use features by logging in or registering!
Log in
Continue as a guest
Log in
Log in
See all the content and easy-to-use features by logging in or registering!
Log in
Language
Resource center
Contact app support
Legal
Home
CPHI Online
Sign up to our Newsletter
Sponsors
